Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Neuro-Degenerative Disease: early-phase trial registry
6 of 12 indexed Neuro-Degenerative Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,429 of 28,707 conditions by registered trial count.
12 US clinical trials · 6 currently recruiting · #1,429 of 28,707 conditions by registered trial count
Neuro-Degenerative Disease: 12 US clinical trials tracked, 6 recruiting.
Neuro-Degenerative Disease is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Drexel University College of Medicine, running 2 of these trials.
Enrollment posture brief
Registry condition neuro-degenerative-disease
OPEN 6 | RECR 50% | LATE 0 | EARLY 2 | RANK #1429 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Neuro-Degenerative Disease lists 6 open slots (50% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Neuro-Degenerative Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Neuro-Degenerative Disease is recruiting above its size-band peers.
6 of 12 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Neuro-Degenerative Disease research.
Drexel University College of Medicine accounts for 2 of 12 trials (16.7%). 11 distinct sponsors appear on at least one study for this condition label.
-
Typical Neuro-Degenerative Disease enrolment sits around 90 participants.
Median target enrolment is 90 among the 12 trials that report a genuine target (sentinel values excluded). 7 of those (58.3%) plan for fewer than 100 participants.
-
Neuro-Degenerative Disease splits between interventional and observational designs.
5 interventional and 7 observational studies make up this index (41.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
12 total, page 1 of 1
The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
National Institute of Mental Health (NIMH)
NCT00271622
Persons With Dementia and Their Extended Family Caregivers
Karen Roberto
NCT04863859
PET Tau - Neurodegenerative Disease Imaging
University of Pennsylvania
NCT03143374
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Carl Allen
NCT04079179
Mindfulness Walking Intervention to Enhance Resilience (iWalk)
University of Illinois at Urbana-Champaign
NCT07285954
A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J
Elpida Therapeutics SPC
NCT06151600
FA Clinical Outcome Measures
Friedreich's Ataxia Research Alliance
NCT03090789
A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders
University of Alabama at Birmingham
NCT03767517
Golf Instruction Versus Tai Chi for People With Parkinson's Disease
Massachusetts General Hospital
NCT03563807
Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population
Drexel University College of Medicine
NCT00718497
Cause and Pathogenesis of Neurometabolic Disorders
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00016562
Cerebrospinal Fluid Repository
Drexel University College of Medicine
NCT00714636
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Neuro-Degenerative Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Neuro-Degenerative Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Neuro-Degenerative Disease page
12 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Neuro-Degenerative Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Drexel University College of Medicine sponsors the most Neuro-Degenerative Disease trials on record, review their full trial history before evaluating a specific study. See Drexel University College of Medicine's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neuro-Degenerative Disease condition card totals 12 registered trials; most-linked intervention Active Intervention; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.